These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12540499)

  • 1. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
    Xu Y; Shibata A; McNeal JE; Stamey TA; Feldman D; Peehl DM
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):23-7. PubMed ID: 12540499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of vitamin D receptor FokI start codon polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal women in Taiwan.
    Chen HY; Chen WC; Hsu CD; Tsai FJ; Tsai CH
    Acta Obstet Gynecol Scand; 2002 Feb; 81(2):93-8. PubMed ID: 11942896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the vitamin D receptor start codon polymorphism (FokI) with bone mineral density in postmenopausal Korean women.
    Choi YM; Jun JK; Choe J; Hwang D; Park SH; Ku SY; Kang D; Kim JG; Moon SY; Lee JY
    J Hum Genet; 2000; 45(5):280-3. PubMed ID: 11043509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women.
    Gennari L; Becherini L; Mansani R; Masi L; Falchetti A; Morelli A; Colli E; Gonnelli S; Cepollaro C; Brandi ML
    J Bone Miner Res; 1999 Aug; 14(8):1379-86. PubMed ID: 10457270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women.
    Gross C; Eccleshall TR; Malloy PJ; Villa ML; Marcus R; Feldman D
    J Bone Miner Res; 1996 Dec; 11(12):1850-5. PubMed ID: 8970885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor start codon polymorphism ( FokI) is related to bone mineral density in healthy adolescent boys.
    Strandberg S; Nordström P; Lorentzon R; Lorentzon M
    J Bone Miner Metab; 2003; 21(2):109-13. PubMed ID: 12601576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones.
    Vezzoli G; Soldati L; Proverbio MC; Adamo D; Rubinacci A; Bianchi G; Mora S
    J Nephrol; 2002; 15(2):158-64. PubMed ID: 12018632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants.
    Gross C; Krishnan AV; Malloy PJ; Eccleshall TR; Zhao XY; Feldman D
    J Bone Miner Res; 1998 Nov; 13(11):1691-9. PubMed ID: 9797477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease.
    Bregenzer N; Schäffler A; Gelbmann CM; Steinkamp M; Reinshagen M; Schölmerich J; Andus T
    Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):1-5. PubMed ID: 16450309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
    Cicek MS; Liu X; Schumacher FR; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2549-52. PubMed ID: 17164384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.
    Huang SP; Huang CY; Wu WJ; Pu YS; Chen J; Chen YY; Yu CC; Wu TT; Wang JS; Lee YH; Huang JK; Huang CH; Wu MT
    Int J Cancer; 2006 Oct; 119(8):1902-7. PubMed ID: 16708371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
    Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
    Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
    Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
    J Hum Genet; 2002; 47(8):413-8. PubMed ID: 12181642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor polymorphisms and lethal prostate cancer.
    Kibel AS; Isaacs SD; Isaacs WB; Bova GS
    J Urol; 1998 Oct; 160(4):1405-9. PubMed ID: 9751364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese.
    Wong HL; Seow A; Arakawa K; Lee HP; Yu MC; Ingles SA
    Carcinogenesis; 2003 Jun; 24(6):1091-5. PubMed ID: 12807755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients.
    Nieto G; Barber Y; Rubio MC; Rubio M; Fibla J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):199-207. PubMed ID: 15225772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
    Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
    Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.